HuGE Literature Finder
Records 1-30
|
Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC.
Molecular therapy. Nucleic acids 2021 Mar 23 89-100. Chong Wei, Wang Zhe, Shang Liang, Jia Shengtao, Liu Jin, Fang Zhen, Du Fengying, Wu Hao, Liu Yang, Chen Yang, Chen H |
|
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.
Cancer immunology, immunotherapy : CII 2021 Jan . Abdel-Wahab Noha, Diab Adi, Yu Robert K, Futreal Andrew, Criswell Lindsey A, Tayar Jean H, Dadu Ramona, Shannon Vickie, Shete Sanjay S, Suarez-Almazor Maria |
|
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.
Cancer immunology, immunotherapy : CII 2021 Jan . Yi Ming, Li Anping, Zhou Linghui, Chu Qian, Luo Suxia, Wu Kongmi |
|
SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Archives of pathology & laboratory medicine 2021 Jan 145 (1): 90-98. Nambirajan Aruna, Singh Varsha, Bhardwaj Nishu, Mittal Saurabh, Kumar Sunil, Jain Deepa |
|
A Gene Mutation Signature Predicting Immunotherapy Benefits in Non-Small Cell Lung Cancer Patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Dec . Pan Dong, Hu Angela Y, Antonia Scott J, Li Chuan-Yu |
|
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma.
Cancers 2020 Dec 12 (12): . Spahn Stephan, Roessler Daniel, Pompilia Radu, Gabernet Gisela, Gladstone Beryl Primrose, Horger Marius, Biskup Saskia, Feldhahn Magdalena, Nahnsen Sven, Hilke Franz J, Scheiner Bernhard, Dufour Jean-François, De Toni Enrico N, Pinter Matthias, Malek Nisar P, Bitzer Micha |
|
EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.
Aging 2020 Dec 12 . Chen Zhiming, Chen Ji, Ren Dandan, Zhang Jiao, Yang Ying, Zhang Henghui, Mao Beibei, Ma Hait |
|
Genetic Heterogeneity of MET-aberrant Non-Small Cell Lung Cancer and its Impact on the Outcome of Immunotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Dec . Kron A, Scheffler M, Heydt C, Ruge L, Schaepers C, Eisert A, Merkelbach-Bruse S, Riedel R, Nogova L, Fischer R N, Michels S, Abdulla D S Y, Koleczko S, Fassunke J, Schultheis A M, Kron F, Ueckeroth F, Wessling G, Sueptitz J, Beckers F, Braess J, Panse J, Grohé C, Hamm M, Kabitz H-J, Kambartel K, Kaminsky B, Krueger S, Schulte C, Lorenz J, Lorenzen J, Meister W, Meyer A, Kappes J, Reinmuth N, Schaaf B, Schulte W, Serke M, Buettner R, Wolf |
|
Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients.
Cancers 2020 Dec 13 (1): . Ramos Romela Irene, Shaw Misa A, Foshag Leland, Stern Stacey L, Rahimzadeh Negin, Elashoff David, Hoon Dave S |
|
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Aging 2020 Dec 12 . Huang Wenwen, Zhao Songhui, Zhang Cheng, Li Zhongwu, Ge Sai, Lian Baofeng, Feng Hui, Wang Kai, Xu Ruihua, Ji Jiafu, Gao Jing, Shi Weiwei, Shen L |
|
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
Aging 2020 Dec 12 . Zhou Pei, Wu Xueying, Chen Huan, Hu Ying, Zhang Henghui, Wu Lijia, Yang Ying, Mao Beibei, Wang Huaqi |
|
Association between tumor mutation burden and immune infiltration in ovarian cancer.
International immunopharmacology 2020 Nov 107126. Fan Suzhen, Gao Xiang, Qin Qiaohong, Li Hongyu, Yuan Zhongfu, Zhao Shuj |
|
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
International immunopharmacology 2020 Nov 107135. Xie Fucun, Bai Yi, Yang Xu, Long Junyu, Mao Jinzhu, Lin Jianzhen, Wang Dongxu, Song Yang, Xun Ziyu, Huang Hanchan, Yang Xiaobo, Zhang Lei, Mao Yilei, Sang Xinting, Zhao Hait |
|
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Aging 2020 Nov 12 . Zhang Jian, Zhong Xi, Jiang Huali, Jiang Hualong, Xie Tao, Tian Yunhong, Li Rong, Wang Baiyao, Zhang Jiexia, Yuan Yaw |
|
Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.
Open forum infectious diseases 2020 Nov 7 (11): ofaa489. Kannambath Shichina, Jarvis Joseph N, Wake Rachel M, Longley Nicky, Loyse Angela, Matzaraki Vicky, Aguirre-Gamboa Raúl, Wijmenga Cisca, Doyle Ronan, Paximadis Maria, Tiemessen Caroline T, Kumar Vinod, Pittman Alan, Meintjes Graeme, Harrison Thomas S, Netea Mihai G, Bicanic Tiha |
|
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.
Journal for immunotherapy of cancer 2020 Nov 8 (2): . Arai Hiroyuki, Xiao Yi, Loupakis Fotios, Kawanishi Natsuko, Wang Jingyuan, Battaglin Francesca, Soni Shivani, Zhang Wu, Mancao Christoph, Salhia Bodour, Mumenthaler Shannon M, Weisenberger Daniel J, Liang Gangning, Cremolini Chiara, Falcone Alfredo, Millstein Joshua, Lenz Heinz-Jos |
|
Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis.
Annals of palliative medicine 2020 Nov 9 (6): 4233-4245. Miao Qian, Zheng Xiaobin, Zhang Longfeng, Jiang Kan, Wu Biao, Lin G |
|
Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients.
Urologic oncology 2020 Nov . Zang Zhijiang, Lim Yew Koon, Chan Yiong Huak, Raman Lata, Esuvaranathan Kesavan, Chiong Edmund, Mahendran Rat |
|
Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy.
Journal for immunotherapy of cancer 2020 Nov 8 (2): . Abed Afaf, Calapre Leslie, Lo Johnny, Correia Suzana, Bowyer Samantha, Chopra Abha, Watson Mark, Khattak Muhammad Adnan, Millward Michael, Gray Elin Solomonov |
|
[Susceptibility genes and risk prediction model of cardiovascular toxicity related to antineoplastic therapy in tumor patients].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2020 Oct 42 (10): 838-842. Liu B L, Ma F, Zeng Y |
|
Association of Homozygous Variants of STING1 with Outcome in Human Cervical Cancer.
Cancer science 2020 Oct . Lubbers Joyce M, Koopman Bart, de Klerk-Sluis Jessica M, van Rooij Nienke, Plat Annechien, Pijper Harry, Koopman Tim, van Hemel Bettien M, Hollema Harry, Wisman Bea, Nijman Hans W, de Bruyn Mar |
|
Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers.
Cancer immunology, immunotherapy : CII 2020 Oct . Zhang Wei, Shi Junping, Wang Yingying, Zhou Hongyuan, Zhang Zewu, Han Zhiqiang, Li Guanghao, Yang Bo, Cao Guangtai, Ke Yan, Zhang Ti, Song Tianqiang, QiangL |
|
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.
Molecular oncology 2020 Oct . Liu Liang, Ahmed Tamjeed, Jeffrey Petty W, Grant Stefan, Ruiz Jimmy, Lycan Thomas W, Topaloglu Umit, Chou Ping-Chieh, Miller Lance D, Hawkins Gregory A, Alexander-Miller Martha A, O'Neill Stacey S, Powell Bayard L, D'Agostino Ralph B, Munden Reginald F, Pasche Boris, Zhang W |
|
Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIs.
Thoracic cancer 2020 Oct . Yang Lu, Hao Xuezhi, Hu Xingsheng, Wang Zhijie, Yang Ke, Mi Yuling, Yang Yaning, Xu Haiyan, Yang Guangjian, Wang Y |
|
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML.
Blood advances 2020 Oct 4 (20): 5011-5024. Vadakekolathu Jayakumar, Lai Catherine, Reeder Stephen, Church Sarah E, Hood Tressa, Lourdusamy Anbarasu, Rettig Michael P, Aldoss Ibrahim, Advani Anjali S, Godwin John, Wieduwilt Matthew J, Arellano Martha, Muth John, Yau Tung On, Ravandi Farhad, Sweet Kendra, Altmann Heidi, Foulds Gemma A, Stölzel Friedrich, Middeke Jan Moritz, Ciciarello Marilena, Curti Antonio, Valk Peter J M, Löwenberg Bob, Gojo Ivana, Bornhäuser Martin, DiPersio John F, Davidson-Moncada Jan K, Rutella Serg |
|
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.
Cancer immunology, immunotherapy : CII 2020 Sep . Wang Qinchuan, Ye Yuanqing, Yu Hao, Lin Shu-Hong, Tu Huakang, Liang Dong, Chang David W, Huang Maosheng, Wu Xife |
|
Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History.
OncoTargets and therapy 2020 13 8795-8802. He Wenwu, Leng Xuefeng, Yang Yanyu, Peng Lin, Shao Yang, Li Xue, Han Yongt |
|
Integrative Analysis of HNF1B mRNA in Human Cancers Based on Data Mining.
International journal of medical sciences 2020 17 (18): 2895-2904. Nie Chunhui, Wang Bei, Wang Baoquan, Lv Ning, Zhang Enf |
|
Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers.
JCO precision oncology 2020 4 . Vu Peter, Khagi Yulian, Riviere Paul, Goodman Aaron, Kurzrock Razel |
|
Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.
Cancer control : journal of the Moffitt Cancer Center 0 27 (1): 1073274820977114. Lei Jiasheng, Zhang Dengyong, Yao Chao, Ding Sheng, Lu Zhe |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: